Atlas Trials

A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia B

Clinical trial NCT02263456 · COMPLETED

Trial details

NCT number
NCT02263456
Sponsor
Bio Products Laboratory
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Haemophilia B
Start date
1997-07-01
Primary completion
2001-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.